Clinical Trial Notification Scheme
For for certain 'Type A' trials notification of the trial to the MHRA is possible.
Type A trials are those involving medicinal products licensed in any EU Member State if:
- they relate to the licensed range of indications, dosage and form; or
- they involve off-label use (such as in paediatrics and oncology, etc) if this off-label use is established practice and supported by sufficient published evidence and/or guidelines.
See the MHRA website for further information.
We would welcome your feedback and suggestions on how we can improve the toolkit. Please help to keep the toolkit up-to-date by reporting any out-of-date content or broken links.Go to form
If you would like to receive occasional email updates about the Clinical Trials Toolkit, please sign up to our mailing list.Sign up
The NIHR funds and manages a number of health research programmes, with ongoing funding opportunities. If you would like information on current NIHR calls for proposals, please visit the NIHR website and relevant programme webpages.Find out more